Nippon India Pharma Fund Direct Bonus is a Equity Mutual Fund Scheme launched by Reliance Mutual Fund. This scheme was introduced to investors on 01 Jan 2013. Sailesh Raj Bhan is the Current Fund Manager of Nippon India Pharma Fund Direct Bonus.The fund currently has an Asset Under Management(AUM) of ₹2,430 Cr and the Latest NAV as of 20 Nov 2019 is ₹160.28.
The Nippon India Pharma Fund Direct Bonus is rated High risk. Minimum SIP Investment is 100. Minimum Lumpsum Investment is 5000. Exit load of 1% if redeemed within 1 year.
Investment Objective
To generate consistent returns by investing in equity or fixed income securities of pharma and other associated companies.
Tax Implications
Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.
Scheme Information Document(SID)
₹5000
Min for First Investment
₹1000
Min for Second Investment
Exit load of 1% if redeemed within 1 year
Exit Load